Please Wait
Applying Filters...
menu
    • menu
    CDMO Activity Tracker: Lupin’s CDMO commissions oncology block in India; Cambrex, Axplora, Hovione expand operations

    Data Compilation
    #PharmaFlow

    Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

    Stock Recap
    #PipelineProspector

    Menu

    Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]-

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 950Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    29/11/2025 Alembic Pharmaceuticals Limited
    India
    		 Zmax Pharmachem Co., Ltd. 20220425-209-J-1225 Leflunomide 2022-04-25 Alembic Pharmaceuticals Limited (API Division Panelav) India AT-Panelav, Tal-Halol, City. Panelav, Dist.-Panchmahal, Gujarat State, India
    29/11/2025 Cipla
    India
    		 UNUST Co., Ltd. 20200922-209-J-748 Leflunomide 2020-09-22 Cipla Limited India Old Madras Road, Virgonagar Post, Bangalore-560 049, India